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In cystic fibrosis (CF), the absence of functional CFTR leads to
dysregulated Na1 absorption across airway epithelia. We estab-
lished an in vitro model of dysregulated Na1 absorption by treating
polarized normal human bronchial epithelial cells (HBEs) with
nystatin (Nys), a polyene antibiotic that enables monovalent cations
to permeate biological membranes. Acute mucosal Nys produced
a rapid increase in short circuit current (Isc) that reflected increased
transepithelial Na1 absorptionand required Na1/K1ATPase activity.
The acute increase in Isc was associatedwith increased mucosal liquid
absorption. Prolonged mucosal Nys treatment resulted in sustained
Na1 hyperabsorption, associated with increased mucosal liquid
absorption in comparison with naı̈ve (nontreated, kept under air–
liquid interface conditions) or vehicle-treated cultures. Nys treat-
ment was not toxic. Increased lactate accumulation in Nys-treated
culture media suggested a higher metabolic rate associated with the
higher energy demand for Na1 transport. After chronic Nys treat-
ment, the increased Isc was rapidly lost when the cultures were
mounted in Ussing chambers, indicating that Nys could be rapidly
removed from the apical membrane. Importantly, chronic Nys
treatment promoted sustained mucosal liquid depletion and caused
mucus dehydration, compaction, and adhesion to the apical surface
of Nys-treated cultures. We conclude that mucosal Nys treatment of
HBEs provides a simple in vitro model to recapitulate the Na1 and
volume hyperabsorptive features of CF airway epithelia.
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In cystic fibrosis (CF) airways, the absence of functional cystic
fibrosis transmembrane conductance regulator (CFTR) protein
results in deficient cAMP-dependent Cl2 secretion and dysregu-
lated Na1 transport (1). This ion transport imbalance leads to
depletion of the airway surface liquid (ASL) volume and impair-
ment in mucus clearance (2), which results in airway obstruction
and increased susceptibility to infection and inflammation (3).
The link among Na1 hyperabsorption, ASL dehydration, and the
onset of CF lung disease has been strongly supported by the
airway phenotype of the recently generated Scnn1b-transgenic
mouse, in which airway-targeted overexpression of the epithe-
lial Na1 channel b subunit (bENaC, encoded by the Scnn1b
gene) resulted in increased epithelial Na1 absorption, ASL
depletion, impaired mucociliary clearance, and airway inflam-
mation (4).
In vitro cultures of human airway epithelial cells have been
widely used to study fundamental aspects of CF and other lung
diseases (5), as these cultures recapitulate many features of the
native respiratory epithelia (6, 7). Although lungs explanted from
patients with CF during transplantation represent a valuable
source of primary CF cells for culture, the availability of such
specimens is limited. Moreover, recent studies have shown that at
least the inflammatory phenotype of primary cultures of CF
airway changes in short-term (6–11 d) versus long-term well-
differentiated (30–40 d) cultures (8). To investigate the specific
contribution of epithelial Na1 hyperabsorption per se to the
development of CF lung disease, there is a need to consistently
reproduce the Na1 hyperabsorptive phenotype of CF airway
epithelia in an in vitro model.
In the present study, we sought to recapitulate the CF-like Na1
hyperabsorptive phenotype in primary cultures of normal human
bronchial epithelial cells (HBEs) by exploiting the pore-forming
capacity of the polyene antibiotic nystatin (Nys), which selec-
tively enables monovalent cations to permeate sterol-containing
membranes. Nys, like another polyene antibiotic amphotericin B,
forms monovalent cation-selective pores with a permeability
sequence of Rb1 . K1 . Na1 . Li1, identical to the size order
of the hydrated ions. Nys has been widely used in perforated patch
recordings to gain electrical access to the cytoplasm while block-
ing the diffusion of cellular constituents into the patch pipette (9).
To establish an in vitro model of transepithelial Na1 hyper-
absorption, we first characterized the response of polarized HBE
cultures to acute mucosal Nys challenge. Next, we evaluated the
effect of prolonged Nys treatment on HBEs by comparing Nys-
treated cultures with nontreated (naı̈ve) and vehicle-treated
(KBR) cultures. We studied the bioelectric properties, changes
in the expression of Na1 transport mediators, toxicity, apical




Primary normal HBEs were provided by the UNC CF Center Tissue
Core and obtained under the auspices of protocols approved by the
Institutional Committee for the Protection of the Rights of Human
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Subjects. HBEs were obtained from freshly excised main stem or lobar
bronchi by protease digestion, directly seeded on 12-mm Transwell Col
membranes (Corning-Costar Corp., Cambridge, MA), maintained in
modified bronchial epithelial growth medium under air–liquid interface
conditions as previously described (10), and studied when transepithe-
lial resistance (RT) was > 300 Vcm2.
Ussing Chamber Measurements
HBEs were plated on 12-mm Snapwell-Clear membranes (Corning-
Costar) pre-coated with human placenta type IV collagen (0.74 mg/ml;
Sigma-Aldrich, St. Louis, MO) in modified bronchial epithelial growth
medium, as described above (10). For acute Nys treatment experiments,
naı̈ve cultures were mounted in Ussing chambers and bilaterally bathed
in Krebs-bicarbonate Ringer (KBR, composition in mM: 140 Na1,
120 Cl2, 5.2 K1, 25 HCO3, 2.4 HPO4, 0.4 H2PO4, 1.2 Ca21, 1.2 Mg21,
5 glucose, pH 7.4) bubbled with 95% O2–5% CO2. Other bathing
solutions included: bilateral Cl2 free KBR, as KBR except all Cl2 was
substituted by gluconate; bilateral HCO32 free KBR, as KBR except
HCO3 was substituted with 1 mM HEPES, 1mM acetazolamide was
added to inhibit cellular bicarbonate production, and the solution was
bubbled with 100% O2; and mucosal high K1 KBR, as KBR except K1
was increased to 100 mM and Na1 reduced to 45 mM. Bioelectric
measurements were performed under short circuit current (Isc) con-
ditions at 378C. Changes in Isc were measured in response to amiloride
(100 mM, mucosal), Nys (40 mM, mucosal), ouabain (1 mM, serosal), or
bumetanide (100 mM, serosal). For chronic Nys treatment experiments,
the transepithelial voltage (VT) and RT of naı̈ve, KBR-, and Nys-treated
cultures were measured with epithelial Voltohmeter (EVOM; World
Precision Instruments, Sarasota, FL) as described in detail below. On the
fourth day of treatment, the cultures were mounted in Ussing chambers
and bilaterally bathed in KBR. Changes in Isc were measured in response
to acute addition of Nys (40 mM, mucosal).
Perfusion Ussing Chamber Measurements
HBE cells were plated on porous Transwell Col filters (insert diameter z
2–3 mm), as previously described (11). After confluence was achieved,
polarized monolayers were mounted in a modified miniature Ussing
chamber connected to a perfusion system that allows rapid (flow rate 3–
5 ml/min, half-time for solution exchange , 3 s) and independent change
of the solutions bathing the apical and basolateral surface of the culture.
Nys (40 mM in KBR) or KBR alone were used as mucosal perfusates,
while KBR was the serosal perfusate in all experiments. For bioelectric
measurements, VT was monitored by a voltage clamp/pulse generator
and the signal recorded. All experiments were performed under open
circuit conditions. To calculate the equivalent current from changes in VT
in response to Nys-challenge, a 1-second current pulse (1 mA) was deliv-
ered across the tissue every 5 seconds. Chord resistances were calculated
at different time points based on the magnitude change in the deflection
of VT, and the equivalent current (Ieq) was calculated using Ohm’s law,
according to a method described by Paradiso and coworkers (11).
Volume Absorption Measurements
We performed two types of ASL measurements. First, ‘‘thin-film’’ mea-
surements of Texas Red–labeled ASL volume (steady-state and kinetic)
were performed with the laser confocal microscopy technique (described
in detail in Ref. 12), using a Zeiss Meta Laser Scanning confocal micro-
scope (Zeiss, Jena, Germany), with a C-Apochromat 403/1.2 NA water
immersion lens (objective working distance 0.29 mm). For steady-state
measurement of ASL height, at t 5 0, 10 ml of Texas Red–labeled (2 mg/
ml) Hepes-buffered saline solution (HBSS, in mM: 130 NaCl; 5 KCl; 1.3
MgCl26H2O; 1.3 CaCl2; 5 glucose, and 10 HEPES salt-free, pH 7.4) was
applied to the mucosal surface and the excess volume aspirated with a
Pasteur pipette to set ‘‘thin film conditions’’ (z 1 ml) and avoid meniscus-
derived artifacts. Due to the fast rate of volume absorption observed in
preliminary experiments in the presence of Nys, for volume absorption
kinetic studies 10 ml of Texas Red dextran–labeled volume, in the presence
or absence of Nys, were layered on the mucosal surface of the cultures and
imaged at different time points (5 min, 30 min, 1 h, 6 h, and 24 h). For all
studies, 100 ml perfluorocarbon (PFC) was added mucosally before
imaging to prevent evaporation of the ASL. To measure the average
ASL height, five randomly selected fields in predetermined areas on the
culture (one central, four circumferential) were scanned in the XZ mode.
Images were then analyzed using the Zeiss LSM 5 Image software, by
measuring ASL height with the calibrated line drawing tool in three
randomly selected points for each image. ASL height data (n 5 3
transwells/condition from two to three different donors) were then
averaged for each condition and time point.
Second, during chronic Nys treatment, macroscopic volume absorp-
tion was measured by quantifying the mucosal liquid still present on
the surface of the cultures at 8 and 16 hours after each mucosal
application of KBR or KBR1Nys. The residual volume was harvested
by gentle suction and its volume measured gravimetrically.
Cell Swelling Measurements
Naı̈ve HBE cultures were bilaterally loaded with 4 mM calcein-AM in
Ham’s F12 medium for 30 minutes at 378C, washed with PBS, and
imaged in the XZ scanning mode using a Zeiss Meta Laser Scanning
confocal microscopy, with a C-Apochromat 403/1.2 NA water immer-
sion lens. After recording the baseline epithelial height at t 5 0, 200 ml
HBSS with or without 40 mM Nys were added to the mucosal surface
and sequential scans were taken every 5 minutes. Cell swelling was
monitored for up to 45 minutes.
Chronic Nys Treatment
A 40 mM sterile stock solution of Nys (Sigma) was prepared in dimethyl
sulfoxide (DMSO), aliquoted, and frozen at 2208C. A new stock solution
was prepared every 2 to 3 weeks. A 1:1,000 dilution was prepared in KBR
before each addition and vortexed. Alternatively, a commercially avail-
able Nys suspension in Dulbecco’s Phosphate Buffered Saline (2 mg/ml,
10,000 units/ml, cell culture tested, endotoxin tested, LPS, 0.016 U/ml;
Sigma) was used as stock solution, with comparable results. The bio-
electric properties of the HBE cultures during chronic Nys treatment
were assessed by measuring the VT and RT with an EVOM. We recorded
the instantaneous VT and RT values after addition of 500 ml KBR to the
apical side of the culture to create a mucosal electrolyte bath suitable for
measurement. Excess KBR was carefully removed from the mucosal
surface by aspiration after each measurement. The equivalent current
(Ieq) was calculated from the VT and RT values according to the Ohm’s
law. After the initial (t 5 0) measurement of VT and RT, 120 ml of KBR
(vehicle, either KBR alone or KBR 1 0.1% DMSO, whenever the Nys
1,0003 stock solution in DMSO was used) or KBR 1 40 mM Nys (Nys)
were mucosally applied to the cultures. KBR or Nys were mucosally
applied twice a day, with an 8-hour interval between the first and the
second application. Naı̈ve cultures were kept under air–liquid interface
conditions throughout the duration of the experiment. Measurements of
VT and RT were performed as described above, every 24 hours there-
after. In Nys-treated cultures, EVOM VT readings reached a peak
immediately after addition of 500 ml mucosal KBR and quickly declined
afterwards. This phenomenon has been also described in toad bladder A6
cells in a similar experimental setting (13). The values reported in Figure
5 correspond to the peak values. A typical chronic Nys treatment
protocol lasted 96 hours. The serosal media of all cultures were replaced
every 24 hours.
Cell Toxicity Assays
To assess cell toxicity, lactate dehydrogenase activity (LDH) was mea-
sured by a colorimetric assay in samples of serosal media collected after
96 hours of chronic Nys treatment. Cell viability after chronic Nys
treatment was also assessed through the LIVE/DEAD Viability/Cyto-
toxicity assay (Invitrogen, Carlsbad, CA). Briefly, after 96 hours of
treatment, naive, KBR-, and Nys-treated cultures were incubated with
3 mM calcein (the green fluorescence of calcein depends on intracellular
esterase activity, which is present only in viable cells) and 4 mM ethidium
homodimer-1 (EthD-1; this dye is excluded by the intact plasma
membrane of live cells, whereas it enters cells with damaged membranes
and, upon binding to nucleic acids, undergoes a 40-fold enhancement of
fluorescence), and imaged by confocal microscopy in XZ scanning mode,
as described above.
Lactate Concentration Assays
Twenty microliters of serosal media from naı̈ve, KBR-, and Nys-treated
cultures were collected at selected time points over the last 24 hours of
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the chronic Nys treatment protocol (i.e., 72, 73, 75, 78, 80, and 96 hours).
Secreted lactate was measured by an enzymatic colorimetric assay (Sigma).
Quantitative Real-Time PCR Analysis of mRNA Abundance
RNA extraction (four Transwells/condition, two donor codes) was per-
formed using the RNeasy mini kit (Qiagen, Valencia, CA). Total RNA
was reverse transcribed into cDNA. Quantification of the mRNA levels
for different transporters was carried on by RT-PCR, using Sybr Green
detection in LightCycler (Roche Diagnostics, Basel, Switzerland) accord-
ing to the manufacturer’s instructions. Specific sequences were amplified
using the following custom made (MWG Biotech, High Point, NC) prim-
ers. Na1/K1ATPase a1 subunit: 59GGA GCT GCT CTG TGC TTT TC;
39GCC CTT TTT GCC CTT TTT AT; Na1/K1ATPase b1 subunit:
59AAG GAG TTT CTG GGC AGG AC; 39GCC ACT CGG TCC
TGA TAT GT; FYXD5: 59GAG CCC CAG ATG CAG TCT AC;
39GGG TCT GTC TGG ACG TCT GT; ENaC a-subunit: 59TGG CAT
GAT GTA CTG GCA AT; 39AGC TCC TCC AGC TCC TCT TT; ENaC
b-subunit: 59TCC GTA GGC TTC AAG ACC AT; 39CAA TAA GGA
CCA GGG GTG TG; ENaC g-subunit: 59ATC GAG TCC AAG CAA
GTG GT; 39GTG GTG GAA AAG CGT GAA AT; NKCC1: 59AAT
GAT GGC CAC TGT TGT GA; 39TTT CTG CAA ATC CAA CCA CA.
Results were normalized on the expression levels of GAPDH mRNA,
primers 59GGA GGT GAA GGT CGG AGT CA; 39GAT CTC GCT
CCT GGA AGA TG.
Immunofluorescence Analysis of a1Na1/K1ATPase Subunit
Immunofluorescent detection of the a1Na1/K1ATPase subunit in HBE
cultures was performed using a mouse monoclonal antibody (Upstate
Technology, Lake Placid, NY). Sections (4–5 mm thick) were obtained
from 4% paraformaldehyde–fixed, paraffin-embedded HBE cultures.
Antigen retrieval was performed by boiling the slides for 15 minutes in
Antigen Unmasking Solution (Vector Laboratories, Burlingame, CA).
Blocking was performed in 10% normal goat serum in PBS, for 1 hour at
378C. The primary antibody was applied to the sections at a 1:200 dilution
in PBS. Mouse IgG1 (Serotec, Raleigh, NC) was used as isotypic control.
The secondary antibody was goat anti-mouse FITC (Jackson Immuno-
research, West Grove, PA), used at 15 mg/ml in PBS and incubated for 30
minutes at room temperature in the dark. Nuclear staining was achieved
by incubation with 0.5 mg/ml propidium iodide in PBS for 5 minutes at
room temperature. Slides were mounted with Vectashield Hard Mount
media (Vector Laboratories) and imaged by confocal microscopy, using
a Leica SP2 microscope (Leica, Wetzlar, Germany), with an Apochro-
mat 403/1.25 NA oil immersion lens, in the XY scanning mode. Images
were acquired using identical illumination intensity and detection sen-
sitivity settings. Quantification of the specific fluorescence signal was
performed using the Metamorph image analysis software (Molecular
Devices, Downington, PA).
Osmium/Perfluorocarbon (OsO4/PFC) Fixation and
AB-PAS Staining
OsO4/PFC fixation followed by Richardson’s staining was performed
according to the protocol described in (14). For AB-PAS staining,
HBE cultures were bilaterally fixed in 4% paraformaldehyde for 15
minutes at room temperature, washed three times with PBS, processed
for inclusion in paraffin, cut, and stained according to the method of
Sheehan and Hrapchak (15).
Mucus Wet/Dry Ratio Measurements
HBE cultures were either maintained in naı̈ve conditions (without
washing of the apical surface) or treated by adding 50 ml of KBR or
KBR 1 40 mM Nys once a day for 14 days to allow accumulation of
visible mucous material. Mucus samples were removed with forceps
and weighed at three timed intervals (30-40-50 s) to allow back-
extrapolation to initial wet weights (16). Mucus samples were desic-
cated for more than 2 hours at 1008C, then reweighed to obtain dry
weights and determine wet/dry ratios and percent solids.
Statistical Analyses
All data are expressed as mean 6 SEM, unless otherwise specified. Paired
Student’s t test and one-way or two-way ANOVA followed by Bonferroni
post-test were used to determine significant differences among groups.
P , 0.05 was considered statistically significant and n represents the
number of different donor lungs from which the cells were obtained.
RESULTS
Acute Apical Membrane Permeabilization with Nys Causes
Na1/K1ATPase-Dependent Na1 Hyperabsorption in Human
Airway Epithelia
To characterize the acute effect of Nys on epithelial ion transport,
we measured HBE bioelectric responses in Ussing chambers.
Addition of Nys (40 mM) to the mucosal bath caused a large
increase in Isc (Figure 1A) and a decrease in RT (Figure 1B). The
increase in Isc was transient and, after a progressive decline (z 1
hour), Isc returned approximately to basal levels (Figure 1A, inset,
peak [A] and t . 200 min after challenge [B] values). The effect of
Nys on Isc was dose dependent, with the half-maximal activation
(EC50) in the range of 30 mM (Figure 1C). Although character-
ized by a common pattern (rapid increase, peak, gradual de-
crease), the profiles of Nys-induced Isc varied among different
cultures, even those derived from the same donor, perhaps
reflecting differences in Nys insertion in the apical membrane.
To test whether the gradual decrease in Isc could reflect
inactivation/loss of Nys pores, we used a modified Ussing cham-
ber that allows continuous perfusion of the mucosal surface. HBE
cultures were exposed to pulses of fresh Nys alternating with
KBR washing cycles (Figure 1D). After the first exposure to Nys,
which induced a strong peak in Ieq followed by relaxation, the
subsequent exposures failed to elicit a peak response of similar
magnitude to the first exposure and produced progressively
smaller Ieq peak responses. The Ieq responses to the subsequent
Nys pulses, however, always exceeded baseline values. Notably,
KBR washes appeared to quickly remove Nys pores from the
mucosal surface, returning Ieq to pre-challenge baseline levels.
Based on the mechanism of action and ion selectivity of Nys
pores, we hypothesized that the initial Isc peak response was
dominated by a Nys-induced intracellular Na1 load that induced
an increase in Na1/K1ATPase activity. To test whether the Nys-
induced increase in Isc was indeed carried by Na1, we compared
the response to acute Nys challenge in the presence or absence
of Na1 in the luminal bath, replacing Na1 with N-methyl-D-
glucamine (NMDG) before challenging the cultures with Nys. As
shown in Figure 2A (representative tracings and summary bar
graphs with average peak Isc responses), Na1 substitution signif-
icantly blocked the Nys-induced Isc peak response.
Since NMDG is impermeable through the Nys pores and likely
also has lower permeability than Na1 through the paracellular
pathway, replacement of Na1 with NMDG alone might cause
a decrease or reversal of the Isc due both to limitation of cellular
Na1 entry and establishment of a bionic potential across the
paracellular pathway (shunt current). To estimate the magnitude
of the shunt current in the presence of NMDG in the apical
chamber, we treated HBEs with amiloride (mucosal, 100 mM) to
block the mucosal-to-serosal, transcellular Na1 pathway (17, 18).
Amiloride produced the expected decrease in Isc (Figure 2B, gray
and black tracings, DIsc Amil in the bar graph). Upon Na1
substitution with NMDG in the apical chamber (Figure 2B, gray
tracing), we observed a further decrease in Isc from the amiloride-
treated values (DIsc Amil/NMDG in the bar graph). This further
decrease in Isc likely reflects the larger serosal-to-mucosal Na1
movement, compared to the mucosal-to-serosal NMDG move-
ment, through the paracellular pathway (shunt current). Addition
of Nys to amiloride-pretreated cultures in the presence of a nor-
mal Na1 concentration (140 mM) in the mucosal bath produced
a large increase in Isc (Figure 2B, black tracing), whereas this
increase in Isc was substantially reduced when Nys challenge was
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preceded by amiloride and Na1 replacement with NMDG (Fig-
ure 2B, gray tracing). Because the Isc response to NMDG after
amiloride pretreatment (shunt current) was small (z 7 mA/cm2),
the contribution of the shunt current to the large reduction in Nys-
induced Isc with mucosal amiloride/NMDG was small (compare
the DIsc Amil1Nys with the DIsc Amil/NMDG1Nys, z 90 mA/
cm2). Moreover, the observation that amiloride pretreatment did
not block the Nys peak response (compare DIsc Amil1Nys in
Figure 2B with DIsc KBR1Nys in Figure 2A) suggests that Nys
creates an ENaC-independent, unregulated path for Na1 entry as
expected based on Nys’ mechanism of action.
To test whether the Nys-induced Isc was dependent on the
activity of the basolateral Na1/K1ATPase, we tested the effect
of ouabain (1 mM, serosal), a specific inhibitor of the Na1/
K1ATPase, on the Isc response elicited by acute Nys challenge.
As shown in Figure 2C, pretreatment with ouabain significantly
blunted the Nys-induced increase in Isc, demonstrating that the
Nys-induced Isc response required the activity of the Na1/
K1ATPase.
Next, we explored the possibility that the Nys-induced in-
crease in Isc was due to serosal-to-mucosal anion movement. We
tested the effect of blocking Cl2 transport on the Nys-induced Isc
peak response by inhibiting Cl2 entry through the Na-K-2Cl
cotransporter (NKCC), located in the basolateral membrane of
airway epithelial cells, with bumetanide (100 mM). As shown in
Figure 3A, inhibition of Cl2 entry did not significantly inhibit the
Nys-induced Isc peak response, consistent with the notion that the
Nys-induced DIsc predominantly reflected increased Na1 absorp-
tion.
We also tested the effect of acute Nys challenge on HBE bio-
electrics in the complete absence of Cl2 on both sides of the
epithelium. The Nys peak was significantly blunted in bilateral
Cl2-free KBR as compared to bilateral KBR conditions (Figure
3B). Although it is possible that a portion of the Isc peak response
to Nys is due to Cl2 secretion, the striking discrepancy between
the absence of a bumetanide effect on Nys peak response and the
inhibition of the Nys response by complete removal of Cl2 might
be explained by the analysis of the effect of Cl2 substitution on
the electrochemical driving force for Na1 entry. Based on pre-
vious studies (19), removal of Cl2 from the apical compartment
would significantly depolarize the apical membrane (e.g., re-
duction of luminal Cl2 to 3 mM depolarized the apical membrane
DVa 1 12.1 mV). Further, bilateral Cl2 substitution is predicted to
induce cell shrinkage and a consequent increase in intracellular
Figure 1. Acute Nys challenge causes a dose-dependent
Isc increase in primary HBE cells. (A) Representative Ussing
chamber tracing illustrating the Isc (A) and RT (B) response
of naı̈ve HBEs to acute Nys challenge. Inset in A: bar
graph showing average peak response (A) and t . 200
min after challenge values (B), mean 6 SEM, n 5 11.
(C) Cumulative dose–response curve for the effect of
Nys on Isc in naı̈ve HBEs. Data are shown as mean 6
SEM, n 5 7. (D) Representative tracing for measure-
ments of Ieq in a modified perfusion Ussing chamber.
Arrows indicate changes of the mucosal perfusate
(Nys 5 40 mM Nys in KBR, wash 5 KBR).
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Na1 activity. Thus it is likely that bilateral Cl2 substitution
reduced the Isc response to Nys because the electrochemical
driving force for Na1 entry was substantially reduced by the Cl2
substitution maneuver.
To exclude the participation of other relevant anions in the
acute Nys peak response, we performed challenges in the ab-
sence of HCO32. We observed peak responses equivalent to
those measured in the presence of HCO32 (Figure 3C).
Interestingly, when HBEs mucosally bathed in high K1 KBR
were challenged with Nys, the peak response was strikingly en-
hanced (Figure 3D). These data suggest that when K1 efflux
through the Nys pores is prevented by elevation of the luminal
[K1], the absolute magnitude of net Na1 influx is revealed. As
previously reported, elevation of the extracellular [K1] did not
affect HBE bioelectrics in the absence of Nys (20).
Taken together, these data demonstrate that mucosal appli-
cation of Nys to HBEs induces predominantly Na1 absorption
that is dependent on Nys concentration and Na1/K1ATPase.
However, as another measure of the net ion transport triggered
by Nys, we measured luminal liquid volume transport.
Acute Nys Challenge Promotes Mucosal Volume Absorption
In airway epithelia, transepithelial Na1 transport constitutes the
driving force for liquid absorption from the luminal compart-
ment. To test whether Na1 hyperabsorption induced by acute Nys
challenge was coupled to an increased mucosal volume absorp-
tion by HBEs, we performed thin film measurements of ASL
volume absorption using live cell confocal imaging, as previously
described (12). Figure 4A shows representative images taken in
the XZ scanning mode after establishment of thin-film conditions
(ASL volume z 1 ml) on naı̈ve HBEs in the absence or presence of
Nys (HBSS and HBSS1Nys, t 5 0), and after 1 hour of incubation
in a highly humidified incubator (t 5 1 h). In the absence of Nys,
we observed ASL heights in the 7 mm range, as expected for
Figure 3. Contribution of Cl2, HCO32, and K1 to the response of HBEs
to acute Nys treatment. Representative Ussing chamber tracings illus-
trating the Isc response to acute Nys challenge (Nys, dashed line) in
bumetanide-treated (A, Bum, gray tracing); bilateral Cl2 free KBR (B, Cl2
free, gray tracing); bilateral HCO32 free KBR (C, HCO32 free, gray tracing);
and mucosal high K1 KBR (D, high K1, gray tracing) compared with
untreated HBEs (black tracing). Compiled data from the experiments
depicted in all panels are shown in the bar graph as mean 6 SEM, n 5 2 to
3 individual donors, 4 to 6 cultures/condition. *P , 0.0001 versus Nys/
KBR. Average peak Isc responses to Nys are shown in all the bar graph.
Figure 2. Acute Nys challenge causes Na1 hyperabsorption in primary
HBE cells. (A) Representative Ussing chamber tracings illustrating the Isc
response of naı̈ve HBEs to acute Nys challenge (Nys, vertical dashed line)
after Na1 replacement (mucosal NMDG, gray tracing) or without
Na1 replacement (black tracing). Compiled data from the experiment
depicted in A are shown in the bar graph as mean 6 SEM, n 5 3 indi-
vidual donors, 3 to 4 cultures/condition; *P , 0.0001 versus KBR1Nys.
(B) Representative Ussing chamber tracings illustrating the Isc response
to acute Nys challenge (Nys, vertical dashed line) of HBEs pretreated
with amiloride (Amil, mucosal) and subjected or not to Na1 replace-
ment with NMDG (gray and black tracing, respectively). Compiled
data from the experiment depicted in B are shown in the bar graph as
mean 6 SEM, n 5 3 individual donors, 3 to 4 cultures/condition; *P ,
0.0001 versus Amil1Nys. (C) Representative Ussing chamber tracings
illustrating the Isc response to acute addition of Nys (Nys, vertical
dashed line) in ouabain-treated (Ouab, gray tracing) and untreated
HBEs (black tracing). Compiled data from the experiments depicted in
C are shown in the bar graph as mean 6 SEM, n 5 3 individual donors,
3 to 4 cultures/condition; *P , 0.0001 versus Nys/KBR. Average peak Isc
responses to Nys are shown in all the bar graphs.
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normal HBEs. In contrast, the presence of Nys in the mucosal
liquid significantly increased the volume absorptive capacity of
HBEs. Importantly, as shown in Figure 4B, in the presence of Nys
the steady-state ASL height dropped well below 7 mm, the
physiologic threshold previously shown to be essential for main-
taining proper ciliary beating and mucus clearance (2). Thus, Nys
produces an apical Na1 channel that is not appropriately regu-
lated (inhibited) at low ASL volumes.
To define the volume absorption kinetics of HBEs in the pres-
ence and absence of mucosal Nys, 10 ml of Texas Red dextran-
labeled volume with or without Nys were layered on the mucosal
surface of the cultures and imaged at serial time points (5 min,
30 min, 1 h, 6 h, and 24 h). Figure 4C shows that Nys promoted
a faster rate of volume absorption (z 5 mm/min in the absence of
Nys compared with z 20 mm/min in the presence of Nys) that
significantly reduced ASL height below the 7 mm threshold
(dashed line). This reduction persisted throughout the 24-hour
observation period. Collectively, these data indicate that Nys
both accelerates the rate of volume absorption and bypasses the
physiologic inhibition of Na1 absorption at low ASL volumes.
Figure 4. Acute Nys challenge promotes
mucosal volume absorption in HBEs and
induces cell swelling in the presence of
large mucosal volume. (A) Representative
XZ confocal images of HBEs loaded with
Calcein-AM (green signal) and layered
with Texas Red–labeled ASL volume (thin
film conditions, red signal) in the absence
(HBSS) or presence of Nys (HBSS1Nys), at
t 5 0 (upper panels) and t 5 1 hour of
incubation in highly humidified incubator
(lower panels). Scale bar 5 10 mm. (B)
Compiled data from thin film measure-
ments of steady state ASL volume. Data
are expressed as ASL height and shown as
mean 6 SEM, n 5 4 individual donors, 2
cultures/condition; *P , 0.0001. (C) Ki-
netic measurements of ASL volume ab-
sorption by naı̈ve HBEs in the absence
(HBSS) or presence of Nys (Nys). (D) Representative sequence of XZ confocal images of calcein-loaded naive HBEs used for cell swelling measurements
upon acute Nys challenge in the presence of large mucosal volume. At t 5 1 minute, 200 ml of Texas Red–labeled HBSS (upper panel) or HBSS1Nys (lower
panel) were mucosally applied. Scale bar 5 10 mm. (E) Compiled data for epithelial cell swelling measured as increase in epithelial height over baseline
(t 5 0) at 15 minutes. Data are shown as average 6 SEM, n 5 3 individual donors, 2 cultures/condition; *P , 0.01 versus HBSS.
Figure 5. Chronic mucosal Nys treatment promotes sustained
Na1 hyperabsorption in airway epithelial cells in the absence of
cell toxicity. (A–C) EVOM measurements of HBEs bioelectric
properties in naı̈ve, KBR-, and Nys-treated cultures. (A) trans-
epithelial voltage (VT); (B) transepithelial resistance (RT); and
(C) calculated equivalent current (Ieq). Data are shown as mean
6 SEM, n 5 6 individual donors, 2 to 4 cultures for each
treatment, *P , 0.001 significantly different vs. naı̈ve cultures.
(D) Representative images illustrating the absence of ethidium
homodimer-1 staining (marker of cell death) in naı̈ve, KBR-, and
Nys- treated cells subjected to the DEAD/LIVE cell fluorescence
assay. Positive control 5 digitonin-treated HBEs. (E) Lactate
dehydrogenase (LDH) activity in the basolateral media of naı̈ve,
KBR-, and Nys-treated cultures after 96 hours of Nys treatment.
Data are shown as mean 6 SEM, n 5 3 individual donors, 2
cultures for each treatment. (F) Time-course of lactate accu-
mulation in the serosal media of naı̈ve, KBR-, and Nys-treated
cultures. Data are shown as mean 6 SEM, n 5 4 individual
donors, 2 cultures for each treatment; *P , 0.001 Nys versus
naı̈ve and KBR-treated cultures, dP , 0.001 KBR versus naı̈ve
cultures.
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Acute Nys Challenge in the Presence of Large Mucosal
Volume Causes Cell Swelling
The initial uncontrolled intracellular Na1 load elicited by Nys
permeabilization of the apical cell membrane is predicted to
promote cell swelling if a large volume of liquid is present on
the mucosal surface. To study changes in cell volume, we per-
formed real time imaging of calcein-loaded HBEs after apply-
ing to the apical surface 100 to 200 ml of liquid to the apical
surface in the presence or absence of Nys. As shown in Figure
4D, addition of Nys in a large mucosal volume induced a gradual
and significant cell swelling as compared with HBEs exposed to
the same volume load without Nys (HBSS). In the presence of
Nys, the epithelial height reached a plateau in approximately 15
minutes and the cells remained swollen for over 45 minutes
(data not shown). The percentage change in t0 epithelial height
at 15 minutes, in the absence or presence of Nys, is depicted in
Figure 4E. Previous studies have shown that mucosal addition
of amphotericin B increased the intracellular Na1 activity from
23 to 65 mM, with bioelectric changes similar to those induced
by Nys (7). Thus, HBE cell swelling in the presence of a large
mucosal volume is consistent with a Nys-induced increase in
intracellular NaCl, followed by osmotically driven water influx.
Although we could not assess whether volume absorption was
taking place over the 45-minute period of observation (ASL
height exceeded the objective working distance), the data shown
in Figures 5A and 7A below indicate that acute cell swelling in
Figure 6. Chronic mucosal
Nys treatment does not af-
fect the bioelectric proper-
ties of primary HBE cells nor
total mRNA abundance of
transepithelial Na1 trans-
port mediators. (A) Repre-
sentative Ussing chamber
tracings showing the effect
of chronic Nys and KBR
treatment on Isc. The en-
larged panel shows the
rapid loss (completed in z
15 min) of chronic Nys ef-
fect (e.g., increased Isc)
upon mounting of the cul-
tures in a Nys-free mucosal
bath. (B) Baseline Isc values
15 minutes after mounting
naı̈ve, KBR-, and Nys-trea-
ted culture in the chambers
(data are shown as mean 6
SD, n 5 4 individual donors,
4 to 6 cultures for each
treatment; *P 5 0.01 versus
naı̈ve cultures). The arrow in
Figure 1A indicates the
acute addition of Nys in
the apical chamber. (C) DIsc
between peak value after
acute Nys addition and
baseline value (peak-basal);
(D) DIsc value between the
Isc value at 40 minutes and
baseline value and (40min-
basal). Data are expressed
as mean 6 SEM, n 5 4 in-
dividual donors, 4 to 6 cul-
tures for each treatment; *P
, 0.05 versus naı̈ve cul-
tures. (E) Quantitative RT-
PCR analysis of epithelial
Na1 transport path compo-
nents in naı̈ve, KBR-, and
Nys-treated cultures after 8
hours of treatment. Similar
data were obtained at (F) 24
hours and (G) 96 hours of
treatment. Data are shown
as mean 6 SEM, n 5 2 in-
dividual donors, 4 cultures for each treatment. (H) Representative confocal images of naı̈ve, KBR-, and Nys-treated HBE cultures immunostained for
a1 Na1/K1ATPase. Quantification of the a1Na1/K1ATPase-specific signal is shown in the bar graph as mean 6 SEM, n 5 3 individual donors, 2 cultures
for each treatment. *P , 0.05 significantly different versus naı̈ve and KBR-treated cultures.
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the presence of large mucosal volume did not affect epithelial
integrity or prevent mucosal volume absorption.
Chronic Mucosal Nys Treatment Promotes Sustained Na1
Hyperabsorption in Airway Epithelial Cells
To mimic more closely the chronic Na1 hyperabsorption present
in CF airway epithelia, we next evaluated the effect of chronic Nys
treatment (40 mM mucosal Nys for 4 d) on HBEs by comparing
the bioelectric properties (measured by EVOM voltohmeter
during the treatment, as described in MATERIALS AND METHODS)
of Nys-treated cultures with both nontreated (naı̈ve) and vehicle
(KBR)-treated cultures. As shown in Figure 5A, chronic mucosal
Nys treatment increased VT over time, whereas naı̈ve or KBR-
treated cultures exhibited no change in VT. After 96 hours of
treatment, Nys-treated cultures exhibited a lower RT compared
to naı̈ve cultures, whereas in KBR-treated cultures we observed
a slight increase of RT in comparison to naı̈ve cultures (Figure
5B). Of note, after the first 24 hours of treatment, Nys-treated
cultures maintained steady RT values of approximately 200 Vcm2
for 4 days, indicating that epithelial integrity was preserved. The
equivalent current (Ieq) of Nys-treated cultures was significantly
increased over time compared to naı̈ve and KBR-treated cultures
(Figure 5C). After 4 days of Nys treatment, Ieq values reached
a plateau (data not shown).
Chronic Mucosal Nys Treatment Is Not Toxic for Airway
Epithelial Cells
To test in situ whether Nys treatment affected the viability of
HBEs, we performed a cell-based assay using fluorescent probes
that distinguish between live (calcein-positive, green fluores-
cence) and dead (ethidium homodimer-1–positive, red fluores-
cence) cells. We found no evidence that chronic Nys treatment
was toxic for HBEs, whereas dead cells were clearly identified in
the positive control, that is, digitonin-treated cells (Figure 5D).
We next assessed whether chronic Nys treatment had a cytotoxic
effect by measuring lactate dehydrogenase (LDH) activity in the
serosal medium from naı̈ve, KBR-, and Nys-treated cultures after
96 hours of treatment. As shown in Figure 5E, no difference in
LDH levels among the different conditions was detected.
Chronic Mucosal Nys Treatment Increases Serosal Lactate
Secretion by Airway Epithelial Cells
We noticed that, during chronic Nys treatment, KBR- and Nys-
treated cultures tended to acidify the basolateral media (in-
dicated by a shift toward yellow in phenol red–containing media)
more rapidly than naı̈ve cultures. We speculated that the higher
transepithelial Na1 transport induced by Nys was coupled to
increased energy expenditure. Since primary epithelial cells in
prolonged culture conditions usually rely on glycolytic metabo-
lism (21), we performed time courses for the accumulation of
lactate (the end product of the glycolytic metabolism) in the
serosal media of naı̈ve, KBR-, and Nys-treated cultures. As
shown in Figure 5F, 24-hour lactate accumulation after 96 hours
of treatment was higher in Nys- than either KBR-treated or naı̈ve
cultures, whereas the lactate levels of KBR-treated cultures were
intermediate between naı̈ve and Nys-treated cultures. These data
suggest that Nys- and, to a lesser extent, KBR-treated cultures
exhibited a higher metabolic energy demand, likely associated
with increased Na1 transport/volume load.
Chronic Mucosal Nys Treatment Does Not Permanently
Change the Bioelectric Properties of Airway Epithelial Cells
We next tested whether chronic Nys treatment would perma-
nently affect the bioelectric properties of HBEs as measured in
Ussing chambers. The representative tracings shown in Figure 6A
were recorded immediately after mounting in the chambers
cultures chronically treated for 96 hours. We found that the
Nys-induced increase in Isc (illustrated in Figure 5C) waned
within 5 minutes after the culture was bathed in bilateral KBR
(see Figure 6A, inset). These data suggest that, even after
prolonged treatment, Nys binding to the apical membrane was
weak, and it was rapidly reversible when Nys was diluted more
than 40-fold in the mucosal bath. These findings are in agreement
with the perfusion chamber experiment shown in Figure 1D.
After establishment of the new baseline (z 15 min), chroni-
cally Nys-treated cultures exhibited baseline Isc values slightly
lower than those of naı̈ve cultures (see representative tracings in
the inset of Figure 6A and the bar graph with average baseline Isc
values in Figure 6B). All cultures responded to a second Nys
challenge with a rapid increase in Isc, and the average peak values
for Nys-pretreated cultures were slightly smaller than those of
naı̈ve cultures (Figure 6.C). Altogether, these data suggest that
chronic Nys treatment did not grossly modify the basal activity of
the Na1 pump in HBE cells.
Interestingly, for naı̈ve cells, the Nys-induced peak in Isc was
followed by a gradual decrease as previously shown (Figure 1A),
whereas for Nys- and KBR-pretreated cultures the Nys-induced
Isc was generally sustained for longer times, as indicated by the
DIsc after 40 minutes in comparison to naı̈ve cultures (Figure 6D).
This latter finding suggests that although the chronic treatment
(both with KBR or Nys) did not alter the ability of the trans-
epithelial Na1 transport system to respond to an acute Na1 load,
it did modify the long-term response of HBEs to this stimulus.
Given the absence of dramatic differences in baseline Isc and Nys-
induced peak Isc values among naı̈ve, chronically KBR–treated,
and chronically Nys–treated cultures and considered the high
variability of late-phase profiles normally obtained upon acute
Nys challenge, we did not further explore the etiology of this long-
term post-Nys challenge response.
Chronic Mucosal Nys Treatment Does Not Affect mRNA
Abundance of Key Elements of the Transepithelial Na1
Transport Path
To assess directly whether chronic Nys treatment modulated the
mRNA abundance of key elements of the transepithelial Na1
transport path, we performed quantitative RT-PCR analysis on
total mRNA extracted from naı̈ve, KBR-, and Nys-treated
cultures at 8, 24, and 96 hours. We evaluated mRNA expression
of the following genes: the catalytic a1Na1/K1ATPase subunit;
the b1Na1/K1ATPase subunit; FXYD5, a newly identified
modulator of the Na1/K1ATPase activity, particularly abundant
in epithelial cells from kidney, intestine, and lung (22); the
basolateral Na-K-2Cl cotransporter (NKCC1); and the three
subunits of the epithelial Na1 channel, i.e., a-, b-, and g-ENaC.
As shown in Figure 6E, no significant differences were detected in
the mRNA abundance among naı̈ve, KBR-, and Nys-treated
cultures after 8 hours of treatment. We obtained similar results
for later time points (e.g., 24 and 96 h [Figures 6F and 6G]),
suggesting that Nys treatment did not affect the mRNA abun-
dance of the major components of the Na1 transport system.
To investigate one aspect of ion transport element regulation
at the protein level, we performed immunofluorescence localiza-
tion studies of the a1Na1/K1ATPase subunit. The immunoloc-
alization pattern in cultured HBE cells (Figure 6H) was in
agreement with the basolateral expression expected for the
Na1/K1ATPase in airway epithelia (23). Similarly to what has
been reported for primary cultures of human nasal epithelial cells
chronically exposed to the polyene antibiotic Amphotericin B
(AmphoB) (23), chronic Nys treatment did not perturb the
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basolateral localization of the Na1/K1ATPase. However, quan-
tification of the a1Na1/K1ATPase-specific fluorescence signal in
naı̈ve, KBR-, and Nys-treated cultures after 96 hours of treatment
revealed a slight but significant increase in the expression of the
a1Na1/K1ATPase in Nys-treated compared with naı̈ve cultures
(Figure 6H), in contrast with chronic AmphoB treatment, which
was found to reduce the expression and activity of the Na1 pump.
Chronic Nys Treatment Promotes Sustained Mucosal Volume
Absorption in Airway Epithelial Cells
HBE cultures chronically treated with Nys or KBR exhibited
striking differences in the rates of absorption of the fluid applied
on their mucosal surfaces. The rate of mucosal volume absorption
was quantified by collecting the fluid remaining on the mucosal
surface at 8- and 16-hour intervals after the application of KBR or
Nys in 120 ml KBR, throughout the chronic treatment protocol.
As shown in Figure 7A, Nys-treated cultures showed a significant
increase in the rate of volume absorption within the first 8 hours of
treatment (9 ml/h with Nys versus 3 ml/h without Nys). The
volume absorption rates increased slightly after the first 8 hours of
treatment and did not change significantly thereafter (16 ml/h
versus 9 ml/h, 15 ml/h versus 6 ml/h, 14 ml/h versus 6 ml/h, and 15 ml/
h versus 7 ml/h, in the presence versus absence of Nys, at 16, 24, 48,
and 72 h, respectively). These data are in agreement with the
findings from Figure 4C, suggesting that Nys promotes liquid
absorption soon after initiation of the treatment. Figure 7B shows
representative images of the mucosal surfaces of naı̈ve, KBR-,
and Nys-treated cultures after 4 days of chronic treatment.
Whereas KBR-treated cultures still had liquid on their surface,
Nys-treated cultures appeared completely dry. Moreover, as
illustrated by the arrowheads in Figure 7B, lumps of what appears
to be mucosal secretions could be seen at the cell surface of KBR-
treated cultures, mostly confined at the periphery of the cell
culture. Similarly, in naı̈ve culture the periphery of the culture is
where most of the mucosal secretions tend to accumulate over
time, likely due to the centrifugal motion of coordinated cilia
beating (not shown). In contrast, mucosal secretions and cell
debris were plastered to the entire cell surface of Nys-treated
cultures, forming macroscopic string-like aggregates.
Chronic Mucosal Nys Treatment Leads to Mucus
Dehydration/Compaction over Airway Epithelial Cells
We investigated at the microscopic level the mucosal surfaces of
naı̈ve, KBR-, and Nys-treated cultures after 4 days of chronic Nys
treatment (Figure 7B) by performing OsO4/perfluorocarbon
fixation to preserve the mucus and periciliary layers as previously
reported (2, 24). As shown in Figure 8A (left panels), both naı̈ve
and KBR-treated cultures exhibited ASL height of approxi-
mately 7 mm, with freely extended cilia. In contrast, Nys-treated
cultures exhibited a depletion of periciliary liquid with ‘‘bent’’
cilia and had a thick layer of dense material adherent to the cell
surface.
To assay for the presence of mucopolysaccharides in this thick
layer, we performed Alcian Blue–Periodic Acid Schiff (AB-PAS)
staining on 4% paraformaldehyde–fixed cultures. This staining
revealed that the dense material on Nys-treated cultures con-
tained mucinous substances (Figure 8A, right panels). Of note,
Nys treatment did not appear to stimulate intracellular accumu-
lation of AB-PAS–positive mucous substances in HBEs (Figure
8A, right panels).
As shown in Figure 8A, after 4 days of treatment the mucous
layer is only about 10 mm thick. Because of the small volume, we
could not collect samples of this material to determine its level of
hydration after 4 days. Therefore, we prolonged the treatment
(decreasing the amount of applied fluid to 50 ml, and the fre-
quency of volume challenge to once a day to prevent prolonged
periods of flooding and hypoxia in KBR-treated cultures) until we
could visually identify masses of mucous material on the surface
of naı̈ve, KBR-, and Nys-treated cultures (i.e., 14 d). We then
collected these secretions, measured the wet/dry ratio, and cal-
culated the percentage of solids as indices of dehydration. As
shown in Figure 8B, the percentage of solids of the mucous
material sampled from the surface of Nys-treated cultures ex-
ceeded those of naı̈ve and KBR-treated cultures, indicating that
such material was markedly dehydrated.
DISCUSSION
In the present study, we sought to model the dysregulated Na1
absorptive phenotype of CF airway epithelia in primary cultures
of normal bronchial epithelial cells with acute and chronic mu-
cosal Nys treatment.
To characterize our model, we first studied the bioelectric
response of HBEs to acute Nys challenge. We found that acute
Nys challenge in primary HBEs produced a dose-dependent,
rapid increase in Isc followed by a gradual relaxation of the re-
sponse (Figure 1A). Diverse responses to acute Nys challenge in
Ussing chambers have been described in the literature. Although
a pattern similar to the one we observed has been described in
toad bladder A6 cells and rat colonic epithelium (13, 25), other
model systems (e.g., Calu-3 cells) responded to acute Nys exposure
with a slower rise in Isc (10–20 min) and a plateau phase that was
sustained for over 30 minutes (26, 27). Since Nys binding to the
plasma membrane is strictly dependent on sterol content (28),
these differences might be attributed to differences in the apical
membrane sterol composition in the different cell types studied.
Detailed characterization using ion substitution and specific
inhibitors of ion transport revealed that the acute bioelectric
response of HBE to Nys challenge reflected multiple ion trans-
port responses, with Na1 absorption being the dominant one. The
initial, steep increase in Isc was dependent on the presence of Na1
in the luminal bath (Figures 2A and 2B) and on the activity of the
basolateral Na1/K1ATPase (Figure 2C). The failure of amiloride
pretreatment to inhibit the Nys-induced Isc peak (Figure 2B) sug-
gested that Nys challenge elicits ENaC-independent Na1 absorption.
Nys-induced Isc was not affected by bumetanide (Figure 3A)
or HCO32 substitution (Figure 3C). However, there was a signif-
icant blunting of this response by bilateral removal of Cl2 (Figure
3B). These results suggest that either Cl2 secretion was a compo-
nent of the Isc response or that Cl2 substitution had an adverse
effect on the electrochemical gradient for Na1 entry across the
apical membrane. The former possibility seems unlikely for three
reasons. First, previous patch clamp studies showed that Nys
forms pores that have a small, finite Cl2 permeability only when
used at high concentrations (150–400 mM) (9). In dog bronchial
epithelial cells, mucosal Nys increased the Cl2 permeability
across the apical membrane only at concentrations higher than
90 mM (29). Lower concentrations of Nys (50 mM), comparable to
the one used in our studies, have been shown to selectively affect
Na1 transport in immortalized Calu-3 human airway epithelial
cells (26). Second, the Nys-induced Isc was insensitive to bume-
tanide (Figure 3A). Third, the possibility that Cl2 secretion was
a component of the Isc response of HBE to acute Nys challenge is
inconsistent with our data showing that Nys treatment enhanced
the volume absorptive properties of HBE both acutely and
chronically (Figures 4A–4C and 7A).
We could also detect evidence of K1 secretion concurrent
with Na1 absorption upon acute Nys treatment (Figure 3D).
However, a greater net rate of Na1 absorption dominated, as
evidenced by the polarity of the Isc response and the liquid
absorption measurements. In agreement with this notion, acute
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Nys administration produced cell swelling (Figure 4D), consistent
with cellular accumulation of Na1 ions and H2O, whereas an
increase in K1 secretion is predicted to produce cell shrinkage.
Cell swelling was not observed in thin film conditions (Figure 4A),
suggesting that Na1 influx through Nys pores, followed by
osmotically driven H2O influx, requested large luminal volumes
to produce cell swelling. Also note that the Nys-induced swelling
was restricted to the luminal columnar cell layer, whereas the
basal cell layer appeared to be unaffected, suggesting that Nys
pores were confined to the apical membrane of the ‘‘mucosal’’ cell
layer (Figure 4D).
In agreement with a previous study (30), we showed that acute
Nys-dependent Na1 hyperabsorption was coupled to a rapid
increase in the rate of mucosal fluid absorption (Figures 4A and
4B). More importantly, the data shown in Figure 4C suggest that
Nys can reproduce both the Na1 transport and the ASL volume
regulation defects associated with CF. Specifically, cultures
exposed to Nys exhibited more rapid initial rate of volume
absorption, consistent with an accelerated rate of Na1 absorp-
tion. Moreover, Nys-treated cultures were unable to inhibit
volume absorption as the ASL volume approached the critical
7 mm threshold required for efficient ciliary beating and mucus
transport. This latter defect (i.e., failure to inhibit ENaC at low
ASL volume) may be the most critical defect in the Na1 transport
path in CF (31) and appears to be mimicked by Nys. In CF the
failure to regulate ENaC at low ASL volume reflects the absence
of functional CFTR (1). With Nys, the absence of Na1/volume
absorption regulation likely reflects the inability of endogenous
regulators of ENaC to inhibit Nys pores (30). Regardless of
mechanistic differences, Nys appears to model both features of
dysregulated Na1 transport exhibited by CF airway epithelia.
To study the effect of chronic apical membrane permeabiliza-
tion, we treated HBE cultures with 40 mM Nys for 4 days. In the
experimental design for the chronic Nys treatment, we consid-
ered two conditions to control for the volume of liquid and mass
of NaCl applied to the Nys-treated cultures, that is, non–volume-
treated (naı̈ve, 0 ml) and volume-treated (KBR, 120 ml) cultures
compared with Nys/volume-treated (Nys1KBR, 120 ml) cultures.
We showed that chronic Nys treatment significantly increased
VT and Ieq over time, while affecting RT only at early time points
Figure 8. Chronic mucosal Nys treatment causes mucus dehydration
and adherence to the cell surface of primary HBE cells. (A) Represen-
tative images of naı̈ve, KBR-, and Nys-treated cultures fixed with OsO4/
PFC and stained with Richardson’s staining (left panels) or fixed with
4% PFA and stained with AB-PAS for detection of mucin molecules
(right panels). Note the thick layer of dense material at the surface of
Nys-treated culture, with embedded cellular debris (arrow). AB-PAS
blue and magenta stain in the intra- and extra-cellular compartments
indicates the presence of acid and neutral mucins, respectively. Scale
bar 5 10 mm. (B) Percent solids content of plugs isolated from the cell
surface of naı̈ve, KBR-, and Nys-treated cultures after long-term (i.e., 14
d) treatment (data are shown as mean 6 SD, n 5 4 individual donors,
2 cultures for each treatment; *P 5 0.001 versus naı̈ve and KBR-treated
cultures).
Figure 7. Chronic mucosal Nys treatment leads to sustained mucosal
volume absorption. (A) Macroscopic determination of mucosal volume
absorption. 120 ml of either KBR or KBR1Nys were mucosally applied to
the cultures (arrows) according to the chronic Nys treatment protocol.
Mucosal liquid volume was estimated every 8 and 16 hours. Data are
shown as mean 6 SD, n 5 4 individual donors, 2 cultures for each
treatment; *P 5 0.018, 8 hours versus 24 hours time point in Nys-
treated cultures. (B) Representative images of the surface of naı̈ve,
KBR-, and Nys-treated cultures after 96 hours chronic Nys treatment.
KBR-culture surface is out of focus for the presence of mucosal liquid
on top of the culture. Note the mucus and cellular debris accumu-
lating towards the periphery of the cultures in KBR-treated cultures
whereas firmly adherent to the cell surface in Nys-treated cultures
(arrowheads).
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(Figures 5A–5C) compared with either control, suggesting that
the functional integrity of the epithelia was preserved.
Transcellular Na1 transport driven by the basolateral Na1/
K1ATPase is an energy-consuming process. Although we found
no signs of overt cytotoxicity induced by the chronic Nys
treatment (Figures 5D and 5E), we observed increased levels of
lactate in the serosal media of KBR- and Nys-treated cultures,
suggesting that both conditions imposed an increased energy
demand on HBE cultures (Figure 5F). We speculate that Nys-
treated cultures faced the highest metabolic energy expenditure
as a consequence of the increased Na1 transport due the in-
creased Na1 permeability in the apical membrane after insertion
of Nys pores. In the case of the KBR-treated cultures, the increase
in lactate concentration in comparison to naı̈ve cultures could
reflect the hypoxic conditions created by the continuous presence
of liquid on the mucosal surface of these cultures. Alternatively,
the higher metabolic energy demand could reflect an increase in
Na1 transport due to the persistent high activation state of ENaC
elicited in airway epithelia by the dilution of ENaC inhibitory
factors normally present in the ASL (30, 32).
A recent study has shown that chronic mucosal treatment
of normal nasal epithelial cells with 50 mM amphotericin B
(AmphoB) significantly reduced VT, Isc, and amiloride-sensitive
Isc (23). AmphoB treatment did not affect cellular metabolism
or integrity, but decreased expression of aENaC, a1Na1/
K1ATPase, and NKCC1. These findings were interpreted to
result from a feedback mechanism aimed to limit cellular Na1
overload due to membrane permeabilization with AmphoB. In
contrast, our data indicate that Nys produced a sustained increase
in Isc (Figures 5A–5C) coupled to increased volume absorption
(Figure 7A) without significant effects on the expression of major
components of transcellular Na1 transport system (Figures 6E–
6H). In the same experimental conditions used in our study, acute
AmphoB challenge caused a rapid increase in Isc similar to the
one elicited by acute Nys (see Figure E1A in the online sup-
plement). Although both Nys and AmphoB belong to the polyene
antibiotic family and, at least acutely, have similar effects on the
bioelectric properties of airway epithelial cells, a comparison
between our results and those of Jornot and coworkers (23)
suggests that the different outcomes might be dependent on the
different interactions of AmphoB versus Nys with the plasma
membrane. For example, our data showed that Nys binding to the
plasma membrane was rapidly reversible, and even after chronic
exposure the bioelectric properties of Nys-treated cultures after
significant Nys dilution, were comparable to those of naı̈ve HBEs.
In contrast, AmphoB interactions with the plasma membrane are
likely stronger, since the time required to recover normal bio-
electric properties depends on the duration of the AmphoB-
exposure (23), regardless of the removal of the drug from the
mucosal solution. Due to the rapid reversibility of the induced
hyperabsorptive phenotype, Nys could be the reagent of choice
when secondary modification of the bioelectric properties of the
cultures or long recovery time after treatment are unwanted.
Importantly, during the chronic Nys treatment protocol, we
observed a striking difference in ASL volume homeostasis be-
tween KBR- and Nys-treated cultures that persisted over 4 days
(Figure 7A). The persistence of this hyperabsorptive response
over 4 days suggests that long-term Nys treatment produced
a sustained increase in HBE Na1 transport. Consistent with
short-term ASL volume experiments in which the mucus layer
was removed from the cell surface (Figures 4A–4C), we found
that after 4 days of chronic Nys treatment, the PCL was depleted
and the cilia were not fully extended (Figure 8A, left panels). In
contrast, naı̈ve and KBR-treated cultures exhibited a normal
ASL phenotype, with the cilia outstretched in an approximately
7-mm high periciliary layer. Further, the cilia and the apical
surface of Nys-treated cultures were covered with a thick layer of
condensed, strongly AB-PAS–positive material (Figure 8A, right
panels). This phenotype strongly resembles the appearance of
mucus-plugged CF airways (33). It is worth stressing that our
ability to still detect the mucous material on the cell surface of
Nys-treated cultures after the repeated washings required for 4%
PFA fixation indicates that the interaction between the con-
densed layer and the epithelial surface was strong.
Assessment of the percentage of solids of mucus plaques
collected after long-term Nys treatment quantitatively showed
that the material lining the surface of Nys-treated cultures was
dehydrated compared with that harvested from naı̈ve or KBR-
treated cultures (Figure 7B). In humans, mucus from bronchiec-
tatic individuals ranges from 4 to 8% solids, whereas CF mucus
ranges from 11 to 20% solids (34). The ‘‘% solids’’ values mea-
sured for the material lining the Nys-treated cultures were higher
than those noted in CF HBE cultures after 3 days in culture (24) or
in CF lungs in vivo. The higher value could reflect the presence of
dead cells in the plugs, as evident in the histologic sections where
cell debris entrapped in the mucus layer can be easily seen (Figure
8A, and Figure E1B in the online supplement). Overall, chronic
Nys treatment did not appear to promote goblet cell hyperplasia
in HBEs. Nevertheless, at this point we can not rule out the pos-
sibility that chronic Nys treatment also promoted mucin hyper-
secretion, perhaps through activation of voltage-sensitive Ca21
channels (35), compounding the effect of dehydration in the
accumulation of concentrated mucus at the mucosal surface.
In conclusion, we have shown that Nys treatment of normal
primary airway epithelial cells recapitulates two key features
characterizing CF airway epithelia: (1) abnormal Na1 transport,
as reflected by both accelerated rate of Na1 absorption and, most
critically, failure to regulate Na1 absorption at low ASL volume,
producing ASL volume depletion on airway surfaces; and (2)
accumulation of dehydrated, ‘‘thickened’’ mucous material that
adheres to the cell surface. The Nys model presents some advan-
tages in comparison to cultured CF HBEs. Besides being in-
expensive and readily available, Nys treatment is not influenced
by culture conditions and it is applicable to a wide variety of
cultured cells, for example, tracheal and bronchial primary,
passage 1 and passage 2 cells, primary nasal cells, and mouse
tracheal cells. However, the Nys model also suffers from limi-
tations. First, the lack of selectivity on cation transport by Nys
pores, (i.e., the parallel increase in K1 as well as Na1 permeabil-
ity) does not strictly model the CF defect. Second, Nys treatment
may exert a subtle pro-inflammatory action on airway epithelial
cells (36) of different nature as the inflammation observed in CF
airways. Third, although we provided evidence of lack of cyto-
toxicity, the details about how HBE cells respond to long-term
intracellular Na1 load are still unknown. Despite these potential
limitations, this simple in vitro model that features luminal
thickened mucus may be useful for characterizing the interactions
of bacteria, inflammatory cells, and soluble factors in a CF-like
luminal milieu. Potentially, this model may also be used to study
the adhesive interaction between mucus layers and airway
epithelial surface, providing data on the mechanisms involved
in mucus adherence and, hence, clues as to novel therapies for CF
lung disease.
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